Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs

This study has been withdrawn prior to enrollment.
(Withdrawn)
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Bruce Psaty, University of Washington
ClinicalTrials.gov Identifier:
NCT00573092
First received: December 12, 2007
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: November 2016
  Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)